Abstract
Background The autonomic nervous system is subserved by the sympathetic and parasympathetic which regulate vital involuntary physiological functions like heart rate. Parasympathetic activity can be measured from the high-frequency component of heart rate variability (HRV), measured via the amplitude of RSA, as a possible predictor for mental health and chronic pain disorders. Therefore, investigators looked to correlate HRV with chronic pain when compared healthy controls.
Methods As part of a larger ongoing study, patients complete pre-defined questionnaires on their pain condition, potential risk factors, and function. For patients and controls investigators collected performance and cardiac measures (RSA, LF-HRV, heart period) while at rest, walking and lifting tests. This analysis focused on differences in heart rate variability measures between 100 patients and 48 controls.
Results Preliminary analysis revealed demographic and anthropometric variables varied significantly between groups. When comparing HRV measures, respiratory sinus arrhythmia (RSA) during lying and sitting were significantly decreased in patients compared to controls while heart period lying and walking were significantly increased in patients. Correlation analysis revealed significant positive correlation between RSA during lying and sitting when looking at age, gender, and weight. Heart periods during lying and walking were negatively correlated with gender and weight.
Discussion To our knowledge it is the first study to look at chronic pain and HRV in the Canadian Forces, while also collecting data on patient reported outcomes, and during various resting and activities. Many potential limitations exist for this study including challenges with respect to controlling for known confounders of heart variability.
Conclusion By establishing heart rate variability as a correlate of chronic pain, the outcome of this project could potentially improve quality of care for patients with these conditions. Further work controlling for confounders and relating HRV to pain severity, subtypes, patient reported outcomes and functional abilities will be required to determine the exact value for clinical decision making.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by HUMAN RESEARCH ETHICS COMMITTEE (HREC) REVIEW Defence R&D Canada - Toronto 1133 Sheppard Avenue West - Toronto - Ontario - Canada - M3K 2C9
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data not available